Dr. Ramya Dwivedi

Dr. Ramya Dwivedi

Feature Writer

Ph.D. Biotechnology

Ramya has a Ph.D. in Biotechnology from the National Chemical Laboratories (CSIR-NCL), in Pune. Her work consisted of functionalizing nanoparticles with different molecules of biological interest, studying the reaction system and establishing useful applications.

See more

She also has had exposure to research in molecular biology, immunology, evolutionary biology, chemistry, AFM imaging and analysis, and spectroscopy. Her interests cover interdisciplinary sciences.

She enjoyed teaching ‘Physics in Nanoscience and Nanotechnology’ as an Assistant Professor at SRM University. After a short period there, she pursued research further as the prestigious CSIR Nehru Science Post Doctoral Fellow in the field of Nanosciences.

Her research helped her skill for writing manuscripts, news articles, and reviews. She has also contributed as a peer reviewer for journals from RSC and ACS publications. After a maternity break and raising two daughters, Ramya is now working to get back into learning, research, and writing.

When Ramya is not immersed in a book, she loves to cook, travel and play with her daughters. She lives in Chennai. She is also a budding gardener. She strongly believes in doing her bit for the environment and in healthy living.

She has recently finished an online course: ‘Writing in the Sciences’, offered by Stanford University. Presently Ramya sees her freelance writing as a primer to her endeavors in science.

See less

Articles from Ramya

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Could a tuna-derived protein inhibit SARS-CoV-2?

Could a tuna-derived protein inhibit SARS-CoV-2?

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

Can biomaterials offer novel therapeutic strategies against COVID-19?

Can biomaterials offer novel therapeutic strategies against COVID-19?

Study of antiviral nutraceutical phenolics against SARS-CoV-2 main protease

Study of antiviral nutraceutical phenolics against SARS-CoV-2 main protease

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

The interaction between blood clotting and SARS-CoV-2 infection

The interaction between blood clotting and SARS-CoV-2 infection

Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?

Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.